Search
Rentosertib
go.drugbank.com/drugs/DB18083InvestigationalSynonyms: 5’-(4-fluorophenyl)-3’-isopropyl-N-(4-(4-methylpiperazin-1-yl)phenyl)-1H,3’H-[2,4’-biimidazole]-4-carboxamide3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
go.drugbank.com/drugs/DB08302ExperimentalSynonyms: 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine
go.drugbank.com/drugs/DB03216ExperimentalSynonyms: (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one
go.drugbank.com/drugs/DB07676ExperimentalSynonyms: 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-oneDexfenfluramine
go.drugbank.com/drugs/DB01191ApprovedIllicitWithdrawnDexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. … For a fairly limited time during the middle of the nineties, the US FDA had approved it for use in managing weight loss.
Synonyms: (S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine, d-N-ethyl-α-methyl-m-trifluoromethylphenethylamineCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesEdoxudine
go.drugbank.com/drugs/DB13421ApprovedWithdrawnEdoxudine is a deoxythymidine analog with activity against herpes simplex virus. It is a potent and selective inhibitor of herpes simplex virus type 1 and 2. … It was later recognized to be effective in vivo in a preclinical model of keratitis caused by herpes virus.
Synonyms: 2'-Deoxy-5-ethyluridine, 5-Ethyl-2'-deoxyuridineCategories: Heterocyclic Compounds, 1-Ring3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid
go.drugbank.com/drugs/DB03548ExperimentalSynonyms: 3-deoxy-α-D-manno-oct-2-ulopyranosonic acid, α-2-keto-3-deoxyoctulosonic acid pyranose2-(p-Tolyl)ethyl nicotinate
go.drugbank.com/drugs/DB16617InvestigationalSynonyms: 3-pyridinecarboxylic acid, 2-(4-methylphenyl)ethyl ester , 2-(p-Tolyl)ethyl nicotinateCamizestrant
go.drugbank.com/drugs/DB19218ApprovedInvestigational[L64094,L64107] The European Commission approved camizestrant on July 23, 2026, Health Canada authorized it on August 4, 2026, and the FDA granted accelerated approval on September 4, 2026. … [L64094,L64107] In pre- or peri-menopausal women and in men, camizestrant plus a CDK4/6 inhibitor is combined with an LHRH agonist or antagonist.
Synonyms: 3-pyridinamine, n-(1-(3-fluoropropyl)-3-azetidinyl)-6-((6s,8r)-6,7,8,9-tetrahydro-8-methyl-7-(2,2,2-trifluoroethyl)-3h-pyrazolo(4,3-f)isoquinolin-6-yl)-, N-(1-(3-fluoropropyl)-3-azetidinyl)-6-((6s,8r)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3h-pyrazolo(4,3-f)isoquinolin-6-yl)-3-pyridinamineCategories: Heterocyclic Compounds, 2-Ring, P-glycoprotein inhibitors5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE
go.drugbank.com/drugs/DB07163ExperimentalSynonyms: 5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE